Reza Roshandel

Papers

Total Citations

H-Index

About

Dr. Reza Roshandel is a rising leader in urological surgery and minimally invasive interventions, whose work is reshaping the landscape of benign prostatic hyperplasia (BPH) treatment. His primary research focus centers on the long-term efficacy and real-world outcomes of Aquablation therapy, a novel, robotically-assisted waterjet ablation technique. Dr. Roshandel’s major contribution lies in providing the most extensive single-center, long-term follow-up data on Aquablation, as evidenced by his landmark 2024 study, "Aquablation at 4-years: Real World Data From the Largest Single-center Study With Associated Outcomes Follow-up." This work, already garnering 9 citations, offers critical evidence on the procedure’s durability, safety, and functional outcomes beyond the typical clinical trial setting. By analyzing a large, diverse patient cohort, he has helped validate Aquablation as a reliable, low-morbidity alternative to traditional surgery, particularly for men with large prostates or complex comorbidities. Dr. Roshandel’s commitment to evidence-based practice and his pioneering use of real-world data are setting new standards for surgical innovation, making him a key voice in the future of urological care.